National Institute for Health and Welfare Research Center Biomedicum   Report issue

Academic/Hospital Phase 3
Founded: Helsinki Finland (2009)

Organization Overview

First Clinical Trial
2019
NCT04101227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

National Institute for Health and Welfare Research Center Biomedicum

Active Ingredients

Drugs in Phase 3 Trials (1)

ondansetron (zofran) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 3)

Alcoholism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1